University of Dundee

Latest News for 05/2022

July 2021

  • SARS-CoV-2 (Credit: Photo by CDC on Unsplash)
    05 Jul 2021

    Seven new papers have been published this month in The Biochemical Journal, representing a major collaboration between multiple groups at the Francis Crick Institute in London, University College London and The University of Dundee.  Led by John Diffley at the Francis Crick Institute, with important contributions in Dundee from the groups of Yogesh Kulathu and Karim Labib in the MRC Protein Phosphorylation and Ubiquitylation Unit, together with Vicky Cowling in the division of Gene Regulation and Expression, the idea was to ‘repurpose’ existing drugs to combat the SARS-CoV-2 virus that caus

December 2020

  • Jorunn Bos and Yogesh Kulathu
    09 Dec 2020

    Two projects led by School researchers have been awarded millions in funding to help develop their pioneering frontier research in life sciences. The European Research Council (ERC) today announced the winners of its latest Consolidator Grant competition, with a total of €655 million awarded to Europe’s top researchers to aid in the development of their research projects.

April 2020

  • 06 Apr 2020

    University of Dundee researchers are studying a protein that aids the spread of COVID-19 in the hope of finding ways of blocking its function. The team, from the University’s Medical Research Council Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU) are working in partnership with the Drug Discovery Unit (DDU) to study an enzyme found within the SARS-CoV-2 virus that causes COVID-19 infection.

April 2018

  • Dominka Kwasna and Syed Arif Abdul Rehman
    04 Apr 2018

    In a paper just published in Molecular Cell, Dominka Kwasna from Yogesh Kulathu’s group at the MRC PPU, in collaboration with Ian Gibbs-Seymour at the University of Oxford, reports the discovery of a completely new class of enzymes that is important for protecting the cell’s DNA from damage.

September 2017

June 2017

  • Yogesh Kulathu
    12 Jun 2017

    Yogesh Kulathu from the MRC Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU) has been awarded a 2017 Lister Research Prize. This prestigious and highly sought-after prize is given annually by the Lister Institute of Preventive Medicine to up to five young researchers in the UK. These awards are intended to help support and nurture future leaders of biomedical research.

June 2016

  • 10 Jun 2016

    In ground-breaking new work published in Molecular Cell, Yogesh Kulathu and colleagues report the discovery of a completely new family of Deubiquitinating enzymes (DUBs). Ubiquitin signals impact a wide range of eukaryotic biology. It is therefore very important that these signals are tightly regulated. This layer of regulation is provided by dedicated proteases called deubiquitinating enzymes (DUBs), of which there are ~100 encoded in the human genome that can be classified into five families.

December 2015

  • 08 Dec 2015

    Yogesh Kulathu awarded €1.5 million ERC Starting Grant Dr. Yogesh Kulathu has been awarded an ERC Starting Grant of €1.5 million which will allow him to initiate an ambitious new project to understand how T-cell biology is regulated by the ubiquitin system. 

November 2013